Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307804915> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4307804915 endingPage "A144" @default.
- W4307804915 startingPage "A143" @default.
- W4307804915 abstract "Abstract Background Pheochromocytomas and paragangliomas (PPGL) are catecholamine-producing neuroendocrine tumors that arise from the adrenal medulla or ganglia and display the highest heritability rate among all human tumours. Genomic analyses allowed identification of molecular subgroups of PPGL which are organized into 2 main clusters. Cluster 1 contains SDHx- and VHL-mutated tumors which do not produce epinephrine while cluster 2 includes the epinephrine-secreting PPGL related to RET, NF1, TMEM127 and MAX mutations. PPGL must be early diagnosed and treated to prevent adrenergic crises which can be life-threatening. Detection of PPGL is particularly important during pregnancy since PPGL are associated with a high risk of either maternal or fetal complications in this context. Reciprocally, pregnancy can favor adrenergic crises in patients with previously undiagnosed or silent pheochromocytoma (PCC). These dangerous events can be triggered by tumor compression resulting from fetus growth, or labor and delivery. However, it is known that surges in plasma catecholamines may also occur during early gestation suggesting that pregnancy may also activate the secretory activity of PPGL through the involvement of non-mechanical factors, such as gestational hormones. Methods In the present study, we report a case of silent PCC revealed in a pregnant woman by life-threatening adrenergic myocarditis occurring at 31 weeks of gestation. Analysis of PPGL susceptibility genes showed the presence of a heterozygous germline RET variant of uncertain significance. The fact that the first symptoms of catecholamine excess had appeared during the first trimester of pregnancy led us to conduct in vitro studies to investigate the effects of estradiol and the pregnancy hormone chorionic gonadotropin (hCG) on epinephrine secretion by cultured cells derived from the resected patient's tumor. Expression of luteinizing hormone/chorionic gonadotropin receptor (LHCGR) was searched for in the tumor and an additional series of 12 PCC by RT-qPCR and immunohistochemistry. LHCGR expression was also analyzed in silico in the PPGL cohorts of the COMETE and The Cancer Genome Atlas (TCGA) databases. Results hCG stimulated epinephrine secretion by primary cultured PCC cells. The tumor expressed the LHCG receptor, which was colocalized with catecholamine-producing enzymes. A similar expression pattern of the LHCG receptor was also observed in 5 out of a series of 12 PCCs. Moreover, in silico studies revealed that PPGL display the highest expression levels of LHCGR mRNA among the 32 solid tumor types of TCGA cohort. Interestingly, expression of LHCGR was higher in cluster 2 than in cluster 1 PPGL. Conclusion We show that PCC can express functional LHCG receptor. Consequently, pregnancy may activate catecholamine production by previously silent pheochromocytoma as early as the first trimester of gestation especially in women with gene mutations that predispose to cluster 2 epinephrine-secreting PCC. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 1:18 p.m. - 1:23 p.m." @default.
- W4307804915 created "2022-11-06" @default.
- W4307804915 creator A5000063112 @default.
- W4307804915 creator A5003059789 @default.
- W4307804915 creator A5006002318 @default.
- W4307804915 creator A5012148485 @default.
- W4307804915 creator A5019512683 @default.
- W4307804915 creator A5029915560 @default.
- W4307804915 creator A5040128812 @default.
- W4307804915 creator A5043545666 @default.
- W4307804915 creator A5055143675 @default.
- W4307804915 creator A5066338957 @default.
- W4307804915 creator A5070355066 @default.
- W4307804915 creator A5081538056 @default.
- W4307804915 date "2022-11-01" @default.
- W4307804915 modified "2023-10-18" @default.
- W4307804915 title "RF33 | PSUN04 Luteinizing Hormone-Chorionic Gonadotrophin Receptor in Pheochromocytomas" @default.
- W4307804915 doi "https://doi.org/10.1210/jendso/bvac150.292" @default.
- W4307804915 hasPublicationYear "2022" @default.
- W4307804915 type Work @default.
- W4307804915 citedByCount "0" @default.
- W4307804915 crossrefType "journal-article" @default.
- W4307804915 hasAuthorship W4307804915A5000063112 @default.
- W4307804915 hasAuthorship W4307804915A5003059789 @default.
- W4307804915 hasAuthorship W4307804915A5006002318 @default.
- W4307804915 hasAuthorship W4307804915A5012148485 @default.
- W4307804915 hasAuthorship W4307804915A5019512683 @default.
- W4307804915 hasAuthorship W4307804915A5029915560 @default.
- W4307804915 hasAuthorship W4307804915A5040128812 @default.
- W4307804915 hasAuthorship W4307804915A5043545666 @default.
- W4307804915 hasAuthorship W4307804915A5055143675 @default.
- W4307804915 hasAuthorship W4307804915A5066338957 @default.
- W4307804915 hasAuthorship W4307804915A5070355066 @default.
- W4307804915 hasAuthorship W4307804915A5081538056 @default.
- W4307804915 hasBestOaLocation W43078049151 @default.
- W4307804915 hasConcept C126322002 @default.
- W4307804915 hasConcept C134018914 @default.
- W4307804915 hasConcept C142724271 @default.
- W4307804915 hasConcept C2775894120 @default.
- W4307804915 hasConcept C2776734335 @default.
- W4307804915 hasConcept C2779234561 @default.
- W4307804915 hasConcept C2779512018 @default.
- W4307804915 hasConcept C46973012 @default.
- W4307804915 hasConcept C54355233 @default.
- W4307804915 hasConcept C71924100 @default.
- W4307804915 hasConcept C86803240 @default.
- W4307804915 hasConceptScore W4307804915C126322002 @default.
- W4307804915 hasConceptScore W4307804915C134018914 @default.
- W4307804915 hasConceptScore W4307804915C142724271 @default.
- W4307804915 hasConceptScore W4307804915C2775894120 @default.
- W4307804915 hasConceptScore W4307804915C2776734335 @default.
- W4307804915 hasConceptScore W4307804915C2779234561 @default.
- W4307804915 hasConceptScore W4307804915C2779512018 @default.
- W4307804915 hasConceptScore W4307804915C46973012 @default.
- W4307804915 hasConceptScore W4307804915C54355233 @default.
- W4307804915 hasConceptScore W4307804915C71924100 @default.
- W4307804915 hasConceptScore W4307804915C86803240 @default.
- W4307804915 hasIssue "Supplement_1" @default.
- W4307804915 hasLocation W43078049151 @default.
- W4307804915 hasLocation W43078049152 @default.
- W4307804915 hasOpenAccess W4307804915 @default.
- W4307804915 hasPrimaryLocation W43078049151 @default.
- W4307804915 hasRelatedWork W1978175539 @default.
- W4307804915 hasRelatedWork W1993439566 @default.
- W4307804915 hasRelatedWork W2032619651 @default.
- W4307804915 hasRelatedWork W2036644978 @default.
- W4307804915 hasRelatedWork W2039472462 @default.
- W4307804915 hasRelatedWork W2046261096 @default.
- W4307804915 hasRelatedWork W2059246703 @default.
- W4307804915 hasRelatedWork W2085317361 @default.
- W4307804915 hasRelatedWork W2204720913 @default.
- W4307804915 hasRelatedWork W2418740601 @default.
- W4307804915 hasVolume "6" @default.
- W4307804915 isParatext "false" @default.
- W4307804915 isRetracted "false" @default.
- W4307804915 workType "article" @default.